ResearcherHokkaido UniversityActive in the last 2 years
Joe Matsumoto
Matched on OpenAlex author ID A5073712807. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study. Co-author DOI 10.1007/s00535-026-02432-2↗
- Seven-year survival with no recurrence after conversion surgery for pancreatic ductal adenocarcinoma with peritoneal metastasis treated with intraperitoneal an… First author DOI 10.3892/mco.2025.2908↗
- Novel aspects of preoperative chemoradiation therapy improving anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1111/cas.12119↗
- Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. Last author DOI 10.1007/s00534-011-0391-8↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Satoshi Hirano · 4 shared papers, 2011–2026 · strength 0.55
- Paper Seven-year survival with no recurrence after conversion surgery for pancreatic ductal adenocarcinoma with peritoneal me… DOI 10.3892/mco.2025.2908↗
- Paper Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nati… DOI 10.1007/s00535-026-02432-2↗
- Paper Novel aspects of preoperative chemoradiation therapy improving anti-tumor immunity in pancreatic cancer. DOI 10.1111/cas.12119↗
- Yumiko Oyamada · 1 shared paper, 2025 · strength 0.30
- Mamoru Takahashi · 1 shared paper, 2025 · strength 0.30
- Hideki Motobayashi · 1 shared paper, 2026 · strength 0.18
- Yosuke Inoue · 1 shared paper, 2026 · strength 0.18
- Masaaki Murakawa · 1 shared paper, 2026 · strength 0.18
- Sohei Satoi · 1 shared paper, 2026 · strength 0.18
- Masamichi Hayashi · 1 shared paper, 2026 · strength 0.18
- Aoi Hayasaki · 1 shared paper, 2026 · strength 0.18
- Takayoshi Nakajima · 1 shared paper, 2026 · strength 0.18
- Yoshitaro Shindo · 1 shared paper, 2026 · strength 0.18
- Masafumi Imamura · 1 shared paper, 2026 · strength 0.18
- Keiko Kamei · 1 shared paper, 2026 · strength 0.18
- Kenjiro Okada · 1 shared paper, 2026 · strength 0.18
- Tsukasa Ikeura · 1 shared paper, 2026 · strength 0.18
- Keinosuke Ishido · 1 shared paper, 2026 · strength 0.18
- Tatsunori Suzuki · 1 shared paper, 2026 · strength 0.18
- Aya Maekawa · 1 shared paper, 2026 · strength 0.18
- Shuji Suzuki · 1 shared paper, 2026 · strength 0.18
- Masayuki Sho · 1 shared paper, 2026 · strength 0.18
- Masamichi Mizuma · 1 shared paper, 2026 · strength 0.18
- Toshimichi Asano · 1 shared paper, 2026 · strength 0.18
- Daisuke Hashimoto · 1 shared paper, 2026 · strength 0.18
- Yoshifumi Takeyama · 1 shared paper, 2026 · strength 0.18
- Kenichiro Uemura · 1 shared paper, 2026 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.